The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
This article highlights the new therapies targeting a specific biomarker that have become available for patients with non–small-cell lung cancer in the past 3 years, significantly improving patient survival. Read More ›
For most patients with cancer, the mRNA COVID-19 vaccines are safe and effective. This article explains the results of the first study that evaluated the safety and effectiveness of the mRNA vaccines in patients with solid cancers, such as lung, breast, or prostate cancer. Read More ›
Unlike many types of cancers, the number of new cases of liver cancer, specifically hepatocellular carcinoma—the most common type of liver cancer—is increasing in the US. Read about the pressures, including the unmet needs, of caregivers of those affected by liver cancer. Read More ›
Myeloproliferative neoplasms, better known as MPNs, are rare and chronic type of blood cancers that develop when the body makes too many red blood cells, white blood cells, or platelets. MPNs are a type of blood cancer that gets worse with time, and because they are chronic, they can last for many years. Read More ›
It’s quite common for patients with cancer to form strong bonds with their oncologists. But it’s not often that patients form connections with researchers, the very scientists who develop cancer therapies that help patients, especially patients facing cancer. Read More ›
Lung cancer is the leading cause of cancer-related deaths in the United States. According to the American Cancer Society, approximately 224,390 people will be diagnosed with lung cancer in 2016, and more than 158,000 patients will die from this disease. Smoking is the major risk factor for lung cancer–80% of lung cancer deaths are related to smoking. Read More ›
The American Cancer Society estimates that 10,380 children under age 15 and about 5,000 teens aged 15 to 19 will be diagnosed with cancer this year in the United States. The rate of children surviving cancer for 5 years or more is growing thanks to improved treatment, but so is the rate of children and teens who are diagnosed with cancer. Read More ›
Lung cancer is the second most common cancer in men and women. Approximately 224,390 new cases of lung cancer will be diagnosed in 2016. Lung cancer kills more Americans each year than any other cancer. Read More ›
Kidney cancers are among the 10 most common cancers in men and women in the United States. According to the American Cancer Society, about 62,700 new cases of kidney cancer will be diagnosed in the United States in 2016, and 14,240 people will die from the disease. Read More ›
On February 11, 2016, the multiple myeloma community lost Pat Killingsworth, one of its most loved and influential patient advocates. Pat was diagnosed with multiple myeloma in April 2007, at age 51. Read More ›